We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Industry Nervous That User Fee Reauthorization Legislation Will Get Bogged Down With Extraneous Asks
Industry Nervous That User Fee Reauthorization Legislation Will Get Bogged Down With Extraneous Asks
The industry is speaking out about worries that must-pass legislation that reauthorizes FDA’s user fee programs might get bogged down with lawmakers’ projects and other effluvium that could alter the agreements FDA and industry have negotiated together.